Fingerlakes BIO Finger Lakes Bio, LLC is a pre-seed startup drug and biologic development company that develops screening and drug testing platforms for pre-IND drug discovery programs focusing on p53. CEO Aaron Wolfe is currently a PhD Candidate in the Physics Department at Syracuse University. Prior to his current position, Aaron co-founded Design Concepts of Niagara, Ltd, which was responsible for developing and marketing the Tow-N-StowTM product with its joint development partner Lippert components (NYSE:DW). As a private venture capital consultant, Aaron was responsible for the due diligence of potential Biotechnology investments. He has also completed course work in finance and entrepreneurism at the Wharton School.
CSO Adam Blanden is currently an MD/PhD Candidate at SUNY Upstate Medical University and NIH Fellow. Adam’s research focuses on the structure and function of p53, with an emphasis on developing drugs to target the protein. Adam currently has 8 peer reviewed publications, and his current work on p53 has resulted in numerous grants and a large venture backed investment for his academic lab to develop compounds for human clinical trials.